HI homepage

Siemens Healthineers CEM and biopsy features cleared by FDA
FDA clears contrast-enhanced mammography, biopsy features for breast imaging system

Interest in CEM has seen significant growth in recent years as more clinical evidence supporting its use has come to light. 

cancer chemotherapy survivor
Radiology nurse navigator helps streamline imaging for breast cancer patients

A new role at the UC Davis Comprehensive Cancer Center is improving the diagnostic process for both patients and providers. 

 Robert Harris, PhD, a machine learning engineer at Virtual Radiologic (vRad), outlined his team's work developing and evaluating a generative chest X-ray machine learning model for use within one of the nation's largest teleradiology practices.
Generative AI chest X-ray models offer new approach to radiology reporting and quality improvement

While the technology remains investigational in many practices, researchers say it has the potential to improve diagnostic accuracy, streamline AI development and strengthen radiology quality assurance.

breast cancer mammography women's imaging
Radiology providers must pay $7M, modify policies after breast cancer miss

Radiologist Henry C. Lusane, MD, with Acumen Medical Imaging, interpreted the scans, reporting the mass as benign, a mistake later leading to a terminal cancer diagnosis. 

Cybersecurity lock
Recently acquired radiology group reports data breach

The Women’s Center for Radiology, which was acquired by Solis Mammography in January, hired a cybersecurity firm to help investigate the scope of the matter. 

Thumbnail
AI cuts hospital system's MRI wait times by more than 50%

The health network, which operates 37 hospitals in California, drastically reduced scheduling delays after integrating an FDA-cleared algorithm designed to speed up imaging acquisition times.  

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.